Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing

Journal of Neuroscience Research

Volumn 85, Issue 11, 2007, Pages 2306-2317

  Sun, June ^a   Xu, Hongzhi ^b   Negi, Sandeep ^b   Subramony, S H ^a   Hebert, Michael D ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Ataxin 1; Ataxin 3; Cajal body; Coilin; Huntingtin; snRNPs

Indexed keywords

ATAXIN 1; ATAXIN 3; HUNTINGTIN; MESSENGER RNA; POLYGLUTAMINE; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ARTICLE; BIOGENESIS; CELL ACTIVITY; CELL INCLUSION; CELL NUCLEUS; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL NUCLEUS; COILED BODIES; FLUORESCENT ANTIBODY TECHNIQUE; GENES, REPORTER; HELA CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRANUCLEAR INCLUSION BODIES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NUCLEAR PROTEINS; PEPTIDES; PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA SPLICING; TRANSFECTION;

EID: 34547627141     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21369     Document Type: Article

References (39)

1. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805-810.
2. Bellare P, Kutach AK, Rines AK, Guthrie C, Sontheimer EJ. 2006. Ubiquitin binding by a variant Jab1/MPN domain in the essential pre-mRNA splicing factor Prp8p. RNA 12:292-302.
3. Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY. 2005. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 14:679-691.
4. Burnett B, Li F, Pittman RN. 2003. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum Mol Genet 12:3195-3205.
5. Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL. 1999. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 8:673-682.
6. Chai Y, Wu L, Griffin JD, Paulson HL. 2001. The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J Biol Chem 276:44889-44897.
7. Chai Y, Berke SS, Cohen RE, Paulson HL. 2004. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem 279:3605-3611.
8. Cioce M, Lamond AI. 2005. Cajal bodies: a long history of discovery. Annu Rev Cell Dev Biol 21:105-131.
9. Collier S, Pendle A, Boudonck K, van Rij T, Dolan L, Shaw P. 2006. A distant coilin homologue is required for the formation of Cajal bodies in arabidopsis. Mol Biol Cell 7:2942-2951.
10. Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, Joazeiro CA. 2003. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci U S A 100:8892-8897.
11. Doss-Pepe EW, Stenroos ES, Johnson WG, Madura K. 2003. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol Cell Biol 23:6469-6483.
12. Frey MR, Matera AG. 1995. Coiled bodies contain U7 small nuclear RNA and associate with specific DNA sequences in interphase cells. Proc Natl Acad Sci U S A 92:5915-5919.
13. Frey MR, Matera AG. 2001. RNA-mediated interaction of Cajal bodies and U2 snRNA genes. J Cell Biol 154:499-509.
14. Gall JG. 2000. Cajal bodies: the first 100 years. Annu Rev Cell Dev Biol 16:273-300.
15. Gatchel JR, Zoghbi HY. 2005. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6:743-755.
16. Grande MA, van der Kraan I, van Steensel B, Schul W, de The H, van der Voort HT, de Jong L, van Driel R. 1996. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J Cell Biochem 63:280-291.
17. Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, Breuer P. 2006. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum Mol Genet 15:555-568.
18. Hong S, Ka S, Kim S, Park Y, Kang S. 2003. p80 Coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product. Biochim Biophys Acta 1638:35-42.
19. Jady BE, Darzacq X, Tucker KE, Matera AG, Bertrand E, Kiss T. 2003. Modification of Sm small nuclear RNAs occurs in the nucleoplasmic Cajal body following import from the cytoplasm. EMBO J 22:1878-1888.
20. Kaytor MD, Duvick LA, Skinner PJ, Koob MD, Ranum LP, Orr HT. 1999. Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet 8:1657-1664.
21. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT. 1998. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41-53.
22. Lam YW, Lyon CE, Lamond AL 2002. Large-scale isolation of Cajal bodies from HeLa cells. Mol Biol Cell 13:2461-2473.
23. Lamond AI, Earnshaw WO 1998. Structure and function in the nucleus. Science 280:547-553.
24. Liu JL, Murphy C, Buszczak M, Clatterbuck S, Goodman R, Gall JG. 2006. The Drosophila melanogaster Cajal body. J Cell Biol 172:875-884.
25. Matera AG. 1999. Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol 9:302-309.
26. Matera AG, Shpargel KB. 2006. Pumping RNA: nuclear bodybuilding along the RNP pipeline. Curr Opin Cell Biol 3:317-324.
27. Moore MJ, Query CC, Sharp P. 1993. Splicing of precursors to mRNA by the spliceosome. The RNA world. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
28. Ross CA. 1997. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19:1147-1150.
29. Saudou F, Finkbeiner S, Devys D, Greenberg ME. 1998. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55-66.
30. Scheel H, Tomiuk S, Hofmann K. 2003. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum Mol Genet 12:2845-2852.
31. Sisodia SS. 1998. Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial? Cell 95:1-4.
32. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A, Zoghbi HY, Orr HT. 1997. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389:971-974.
33. Spector DL. 2001. Nuclear domains. J Cell Sci 114:2891-2893.
34. Sun J, Xu H, Subramony SH, Hebert MD. 2005. Interactions between coilin and PIASy partially link Cajal bodies to PML bodies. J Cell Sci 118:4995-5003.
35. Tucker KE, Berciano MT, Jacobs EY, LePage DF, Shpargel KB, Rossire JJ, Chan EK, Lafarga M, Conlon RA, Matera AG. 2001. Residual Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product. J Cell Biol 154:293-307.
36. Warrick JM, Morabito LM, Bilen J, Gordesky-Gold B, Faust LZ, Paulson HL, Bonini NM. 2005. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol Cell 18:37-48.
37. Watase K, Weeber EJ, Xu B, Antalffy B, Yuva-Paylor L, Hashimoto K, Kano M, Atkinson R, Sun Y, Armstrong DL, Sweatt JD, Orr HT, Paylor R, Zoghbi HY. 2002. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 34:905-919.
38. Yamada M, Sato T, Shimohata T, Hayashi S, Igarashi S, Tsuji S, Takahashi H. 2001. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol 159:1785-1795.
39. Zimber A, Nguyen QD, Gespach C. 2004. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease. Cell Signal 16:1085-1104.